{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:23:24Z","timestamp":1791325404236,"version":"4.3.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"NHS England"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40258-025-00975-8","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T09:44:10Z","timestamp":1746783850000},"page":"779-796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review"],"prefix":"10.1007","volume":"23","author":[{"given":"Laura A.","family":"Trigg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3553-8970","authenticated-orcid":false,"given":"Caroline","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusubramanian","family":"Muthukumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C. F.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"975_CR1","unstructured":"Morga A, Xavier A. Hospital specialists\u2019 private practice and its impact on the number of NHS patients treated and on the delay for elective surgery. Discussion Papers in Economics, No 2001\/01. York: University of York; 2001."},{"key":"975_CR2","unstructured":"NHS England. Delivering plan for tackling the COVID-19 backlog of elective care 2022. Available from: https:\/\/www.england.nhs.uk\/coronavirus\/delivering-plan-for-tackling-the-covid-19-backlog-of-elective-care\/#waiting-list."},{"key":"975_CR3","unstructured":"NHS UK. Guide to NHS waiting times in England 2019. Available from: https:\/\/www.nhs.uk\/nhs-services\/hospitals\/guide-to-nhs-waiting-times-in-england\/."},{"key":"975_CR4","unstructured":"British Medical Association. NHS backlog data analysis 2024. Available from: https:\/\/www.bma.org.uk\/advice-and-support\/nhs-delivery-and-workforce\/pressures\/nhs-backlog-data-analysis."},{"key":"975_CR5","unstructured":"People living in the poorest areas waiting longer for hospital treatment: The King\u2019s Fund and Healthwatch England share new analysis [press release]. London: The King's Fund2021."},{"issue":"1","key":"975_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-6296(96)00506-1","volume":"16","author":"AM Garber","year":"1997","unstructured":"Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;16(1):1\u201331. https:\/\/doi.org\/10.1016\/S0167-6296(96)00506-1.","journal-title":"J Health Econ"},{"key":"975_CR7","unstructured":"NHS UK. Online version of the NHS Long Term Plan 2019. Available from: https:\/\/www.longtermplan.nhs.uk\/online-version\/."},{"key":"975_CR8","unstructured":"National Institute for Health and Care Excellence (NICE). NICE health technology evaluations: the manual. Process and methods [PMG36] London: NICE; 2022. Available from: https:\/\/www.nice.org.uk\/process\/pmg36\/chapter\/introduction-to-health-technology-evaluation."},{"issue":"8","key":"975_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jval.2018.01.017","volume":"21","author":"S Wang","year":"2018","unstructured":"Wang S, Gum D, Merlin T. Comparing the ICERs in medicine reimbursement submissions to NICE and PBAC-Does the presence of an explicit threshold affect the ICER proposed? Value Health. 2018;21(8):938\u201343. https:\/\/doi.org\/10.1016\/j.jval.2018.01.017.","journal-title":"Value Health."},{"issue":"8","key":"975_CR10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jval.2018.02.013","volume":"21","author":"TC Chen","year":"2018","unstructured":"Chen TC, Wanniarachige D, Murphy S, Lockhart K, O\u2019Mahony J. Surveying the cost-effectiveness of the 20 procedures with the largest public health services waiting lists in Ireland: implications for Ireland\u2019s cost-effectiveness threshold. Value Health. 2018;21(8):897\u2013904. https:\/\/doi.org\/10.1016\/j.jval.2018.02.013.","journal-title":"Value Health."},{"key":"975_CR11","unstructured":"Health Information and Quality Authority. Guidelines for the economic evaluation of health technologies in Ireland 2020. 2020."},{"issue":"3","key":"975_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s41669-021-00289-0","volume":"5","author":"JF O'Mahony","year":"2021","unstructured":"O\u2019Mahony JF. Revision of Ireland\u2019s cost-effectiveness threshold: new state-industry drug pricing deal should adequately reflect opportunity costs. Pharmacoecon Open. 2021;5(3):339\u201348. https:\/\/doi.org\/10.1007\/s41669-021-00289-0.","journal-title":"Pharmacoecon Open."},{"issue":"5","key":"975_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/0272989x241256639","volume":"44","author":"NK Gibbs","year":"2024","unstructured":"Gibbs NK, Griffin S, Gutacker N, Villase\u00f1or A, Walker S. The health impact of waiting for elective procedures in the NHS in England: a modeling framework applied to coronary artery bypass graft and total hip replacement. Med Decis Making. 2024;44(5):572\u201385. https:\/\/doi.org\/10.1177\/0272989x241256639.","journal-title":"Med Decis Making"},{"issue":"11","key":"975_CR14","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.socscimed.2004.11.022","volume":"60","author":"MA Koopmanschap","year":"2005","unstructured":"Koopmanschap MA, Brouwer WB, Hakkaart-van Roijen L, van Exel NJ. Influence of waiting time on cost-effectiveness. Soc Sci Med. 2005;60(11):2501\u20134. https:\/\/doi.org\/10.1016\/j.socscimed.2004.11.022.","journal-title":"Soc Sci Med"},{"key":"975_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.socscimed.2015.01.044","volume":"128","author":"A Aakvik","year":"2015","unstructured":"Aakvik A, Holm\u00e5s TH, Kjerstad E. Prioritization and the elusive effect on welfare\u2014a Norwegian health care reform revisited. Soc Sci Med. 2015;128:290\u2013300. https:\/\/doi.org\/10.1016\/j.socscimed.2015.01.044.","journal-title":"Soc Sci Med"},{"issue":"1","key":"975_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11115-018-0425-7","volume":"20","author":"S Elkomy","year":"2020","unstructured":"Elkomy S, Cookson G. Performance management strategy: waiting time in the English national health services. Public Organ Rev. 2020;20(1):95\u2013112. https:\/\/doi.org\/10.1007\/s11115-018-0425-7.","journal-title":"Public Organ Rev."},{"key":"975_CR17","unstructured":"Royal College of Surgeons in England. Types of surgery. Available from: https:\/\/www.rcseng.ac.uk\/patient-care\/having-surgery\/types-of-surgery\/."},{"issue":"2","key":"975_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.healthpol.2004.07.003","volume":"72","author":"JH Luigi Siciliani","year":"2005","unstructured":"Luigi Siciliani JH. Tackling excessive waiting times for elective surgery: a comparative analysis of policies in 12 OECD countries. Health Policy. 2005;72(2):201\u201315. https:\/\/doi.org\/10.1016\/j.healthpol.2004.07.003.","journal-title":"Health Policy"},{"key":"975_CR19","unstructured":"Naomi Kate Gibbs SG, Gutacker N, Villasenor-Lopez A, Walker S. Elective surgery waiting time prioritisation to improve population health gains and reduce health inequalities. Policy Research Unit in Economic Evaluation of Health and Social Care Interventions. Universities of Sheffield and York; 2024."},{"issue":"1","key":"975_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12916-021-02204-0","volume":"20","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMC Med. 2022;20(1):23. https:\/\/doi.org\/10.1186\/s12916-021-02204-0.","journal-title":"BMC Med"},{"key":"975_CR21","unstructured":"National Institute of Health and Care Excellence (NICE). Published: Guidance, quality standards and advice. Available from: https:\/\/www.nice.org.uk\/guidance\/published."},{"issue":"1","key":"975_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"975_CR23","unstructured":"IOE - University College London (UCL). CCEMG\u2013EPPI Centre Cost Converter (v 1.4). Available from: https:\/\/eppi.ioe.ac.uk\/costconversion\/default.aspx."},{"issue":"55","key":"975_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18550","volume":"18","author":"M Brazzelli","year":"2014","unstructured":"Brazzelli M, Cruickshank M, Kilonzo M, Ahmed I, Stewart F, McNamee P, et al. Clinical effectiveness and cost-effectiveness of cholecystectomy compared with observation\/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a systematic review and economic evaluation. Health Technol Assess. 2014;18(55):1\u2013101. https:\/\/doi.org\/10.3310\/hta18550. (v-vi).","journal-title":"Health Technol Assess"},{"key":"975_CR25","unstructured":"National Institute for Health and Care Excellence (NICE). Gallstone disease: diagnosis and management. Clinical guideline [CG188]. Appendix J - full health economic reports London: NICE; 2014. Available from: https:\/\/www.nice.org.uk\/guidance\/cg188\/evidence\/appendix-j-full-health-economic-reports-pdf-6958881109."},{"issue":"6","key":"975_CR26","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s11605-019-04268-z","volume":"24","author":"JM Sutherland","year":"2020","unstructured":"Sutherland JM, Mok J, Liu G, Karimuddin A, Crump T. A cost-utility study of laparoscopic cholecystectomy for the treatment of symptomatic gallstones. J Gastrointest Surg. 2020;24(6):1314\u20139. https:\/\/doi.org\/10.1007\/s11605-019-04268-z.","journal-title":"J Gastrointest Surg"},{"key":"975_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzab018","author":"A Karimuddin","year":"2021","unstructured":"Karimuddin A, Albanese CM, Crump T, Liu G, Sutherland JM. Measuring the impact of delayed access to elective cholecystectomy through patient\u2019s cost-utility: an observational cohort study. Int J Qual Health Care. 2021. https:\/\/doi.org\/10.1093\/intqhc\/mzab018.","journal-title":"Int J Qual Health Care"},{"issue":"1","key":"975_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/s0266462312000657","volume":"29","author":"U Tuominen","year":"2013","unstructured":"Tuominen U, Sintonen H, Aronen P, Hirvonen J, Seitsalo S, Lehto M, et al. Cost-utility of waiting time in total joint replacements: a randomized clinical trial. Int J Technol Assess Health Care. 2013;29(1):27\u201334. https:\/\/doi.org\/10.1017\/s0266462312000657.","journal-title":"Int J Technol Assess Health Care"},{"key":"975_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000752","author":"R Fordham","year":"2012","unstructured":"Fordham R, Skinner J, Wang X, Nolan J. The economic benefit of hip replacement: a 5-year follow-up of costs and outcomes in the Exeter Primary Outcomes Study. BMJ Open. 2012. https:\/\/doi.org\/10.1136\/bmjopen-2011-000752.","journal-title":"BMJ Open"},{"issue":"2","key":"975_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jval.2012.10.020","volume":"16","author":"RE M\u00fajica Mota","year":"2013","unstructured":"M\u00fajica Mota RE. Cost-effectiveness analysis of early versus late total hip replacement in Italy. Value Health. 2013;16(2):267\u201379. https:\/\/doi.org\/10.1016\/j.jval.2012.10.020.","journal-title":"Value Health."},{"issue":"3","key":"975_CR31","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.4081\/or.2017.7161","volume":"9","author":"RE M\u00fajica-Mota","year":"2017","unstructured":"M\u00fajica-Mota RE, Watson LK, Tarricone R, J\u00e4ger M. Cost-effectiveness of timely versus delayed primary total hip replacement in Germany: a social health insurance perspective. Orthop Rev (Pavia). 2017;9(3):7161. https:\/\/doi.org\/10.4081\/or.2017.7161.","journal-title":"Orthop Rev (Pavia)."},{"issue":"12","key":"975_CR32","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.jval.2021.06.004","volume":"24","author":"K Degeling","year":"2021","unstructured":"Degeling K, Corcoran NM, Pereira-Salgado A, Hamid AA, Siva S, Jzerman MJI. Lifetime health and economic outcomes of active surveillance, radical prostatectomy, and radiotherapy for favorable-risk localized prostate cancer. Value Health. 2021;24(12):1737\u201345. https:\/\/doi.org\/10.1016\/j.jval.2021.06.004.","journal-title":"Value Health"},{"issue":"1","key":"975_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1186\/s12885-020-07276-4","volume":"20","author":"S Sanghera","year":"2020","unstructured":"Sanghera S, Mohiuddin S, Coast J, Garfield K, Noble S, Metcalfe C, et al. Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial. BMC Cancer. 2020;20(1):971. https:\/\/doi.org\/10.1186\/s12885-020-07276-4.","journal-title":"BMC Cancer"},{"issue":"1","key":"975_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12885-017-3522-z","volume":"17","author":"C Lao","year":"2017","unstructured":"Lao C, Edlin R, Rouse P, Brown C, Holmes M, Gilling P, et al. The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer. BMC Cancer. 2017;17(1):529. https:\/\/doi.org\/10.1186\/s12885-017-3522-z.","journal-title":"BMC Cancer"},{"key":"975_CR35","unstructured":"National Institute for Health and Care Excellence (NICE). Cataracts in adults: management. NICE guideline [NG77]. Appendix J: Health Economics London: NICE; 2017. Available from: https:\/\/www.nice.org.uk\/guidance\/ng77\/evidence\/appendix-j-health-economics-pdf-167615924437."},{"issue":"4","key":"975_CR36","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/injuryprev-2019-043184","volume":"26","author":"M Boyd","year":"2020","unstructured":"Boyd M, Kvizhinadze G, Kho A, Wilson G, Wilson N. Cataract surgery for falls prevention and improving vision: modelling the health gain, health system costs and cost-effectiveness in a high-income country. Inj Prev. 2020;26(4):302\u20139. https:\/\/doi.org\/10.1136\/injuryprev-2019-043184.","journal-title":"Inj Prev"},{"issue":"5","key":"975_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1177\/1741826711398425","volume":"18","author":"E B\u00f8hmer","year":"2011","unstructured":"B\u00f8hmer E, Kristiansen IS, Arnesen H, Halvorsen S. Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2011;18(5):717\u201323. https:\/\/doi.org\/10.1177\/1741826711398425.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"6","key":"975_CR38","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s40258-021-00663-3","volume":"19","author":"S Martin","year":"2021","unstructured":"Martin S, Lomas J, Claxton K, Longo F. How effective is marginal healthcare expenditure? New evidence from England for 2003\/04 to 2012\/13. Appl Health Econ Health Policy. 2021;19(6):885\u2013903. https:\/\/doi.org\/10.1007\/s40258-021-00663-3.","journal-title":"Appl Health Econ Health Policy"},{"key":"975_CR39","volume-title":"Referral to Treatment (RTT) Waiting Times, England. Monthly RTT data collection. April 2007 to March 2023","author":"NHS England NHS Improvement","year":"2023","unstructured":"NHS England NHS Improvement. Referral to Treatment (RTT) Waiting Times, England. Monthly RTT data collection. April 2007 to March 2023. London: NHS England; 2023."},{"key":"975_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/1471-2458-7-164","volume":"7","author":"JP Oudhoff","year":"2007","unstructured":"Oudhoff JP, Timmermans DR, Knol DL, Bijnen AB, van der Wal G. Waiting for elective general surgery: impact on health related quality of life and psychosocial consequences. BMC Public Health. 2007;7:164. https:\/\/doi.org\/10.1186\/1471-2458-7-164.","journal-title":"BMC Public Health"},{"issue":"5","key":"975_CR41","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/rheumatology\/kep469","volume":"49","author":"F Desmeules","year":"2010","unstructured":"Desmeules F, Dionne CE, Belzile \u00c9, Bourbonnais R, Fr\u00e9mont P. The burden of wait for knee replacement surgery: effects on pain, function and health-related quality of life at the time of surgery. Rheumatology. 2010;49(5):945\u201354. https:\/\/doi.org\/10.1093\/rheumatology\/kep469.","journal-title":"Rheumatology"},{"issue":"5","key":"975_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/hec.864","volume":"13","author":"N Devlin","year":"2004","unstructured":"Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis Health Econ. 2004;13(5):437\u201352. https:\/\/doi.org\/10.1002\/hec.864.","journal-title":"A binary choice analysis. Health Econ."},{"issue":"9","key":"975_CR43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","volume":"26","author":"C McCabe","year":"2008","unstructured":"McCabe C, Claxton K, Culyer AJ. The NICE Cost-Effectiveness Threshold. Pharmacoeconomics. 2008;26(9):733\u201344. https:\/\/doi.org\/10.2165\/00019053-200826090-00004.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"975_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/14737167.2021.1929926","volume":"22","author":"V Low","year":"2022","unstructured":"Low V, Macaulay R. Accounting for inflation within NICE cost-effectiveness thresholds. Expert Rev Pharmacoecon Outcomes Res. 2022;22(1):131\u20137. https:\/\/doi.org\/10.1080\/14737167.2021.1929926.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"7616","key":"975_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/bmj.39308.560069.BE","volume":"335","author":"J Appleby","year":"2007","unstructured":"Appleby J, Devlin N, Parkin D. NICE\u2019s cost effectiveness threshold. BMJ. 2007;335(7616):358\u20139. https:\/\/doi.org\/10.1136\/bmj.39308.560069.BE.","journal-title":"BMJ"},{"key":"975_CR46","doi-asserted-by":"publisher","unstructured":"Martin S, Claxton K, Lomas J, Longo F. The impact of different types of NHS expenditure on health: Marginal cost per QALY estimates for England for 2016\/17. Health Policy. 2023;132:104800.https:\/\/doi.org\/10.1016\/j.healthpol.2023.104800","DOI":"10.1016\/j.healthpol.2023.104800"},{"issue":"1","key":"975_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hec.3130","volume":"24","author":"K Claxton","year":"2015","unstructured":"Claxton K, Sculpher M, Palmer S, Culyer AJ. Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients? Health Econ. 2015;24(1):1\u20137. https:\/\/doi.org\/10.1002\/hec.3130.","journal-title":"Health Econ"},{"issue":"6","key":"975_CR48","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.arth.2021.01.038","volume":"36","author":"RA Wilson","year":"2021","unstructured":"Wilson RA, Gwynne-Jones DP, Sullivan TA, Abbott JH. Total hip and knee arthroplasties are highly cost-effective procedures: the importance of duration of follow-up. J Arthroplasty. 2021;36(6):1864-72.e10. https:\/\/doi.org\/10.1016\/j.arth.2021.01.038.","journal-title":"J Arthroplasty"},{"issue":"1","key":"975_CR49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12891-017-1540-2","volume":"18","author":"H Kamaruzaman","year":"2017","unstructured":"Kamaruzaman H, Kinghorn P, Oppong R. Cost-effectiveness of surgical interventions for the management of osteoarthritis: a systematic review of the literature. BMC Musculoskelet Disord. 2017;18(1):183. https:\/\/doi.org\/10.1186\/s12891-017-1540-2.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7594","key":"975_CR50","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.39129.442164.55","volume":"334","author":"SC Griffin","year":"2007","unstructured":"Griffin SC, Barber JA, Manca A, Sculpher MJ, Thompson SG, Buxton MJ, et al. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ. 2007;334(7594):624. https:\/\/doi.org\/10.1136\/bmj.39129.442164.55.","journal-title":"BMJ"},{"issue":"4","key":"975_CR51","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/2047487320942644","volume":"28","author":"C Forn\u00e9","year":"2021","unstructured":"Forn\u00e9 C, Subirana I, Blanch J, Ferrieres J, Azevedo A, Meisinger C, et al. A cost-utility analysis of increasing percutaneous coronary intervention use in elderly patients with acute coronary syndromes in six European countries. Eur J Prev Cardiol. 2021;28(4):408\u201317. https:\/\/doi.org\/10.1177\/2047487320942644.","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"975_CR52","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1161\/circulationaha.113.003059","volume":"128","author":"WF Fearon","year":"2013","unstructured":"Fearon WF, Shilane D, Pijls NH, Boothroyd DB, Tonino PA, Barbato E, et al. Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. Circulation. 2013;128(12):1335\u201340. https:\/\/doi.org\/10.1161\/circulationaha.113.003059.","journal-title":"Circulation"},{"issue":"12","key":"975_CR53","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3109\/00016340903317990","volume":"88","author":"K Taipale","year":"2009","unstructured":"Taipale K, Leminen A, R\u00e4s\u00e4nen P, Heikkil\u00e4 A, Tapper AM, Sintonen H, et al. Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders. Acta Obstet Gynecol Scand. 2009;88(12):1402\u201310. https:\/\/doi.org\/10.3109\/00016340903317990.","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-00975-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-025-00975-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-00975-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:18:52Z","timestamp":1767169132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-025-00975-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["975"],"URL":"https:\/\/doi.org\/10.1007\/s40258-025-00975-8","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"28 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article was originally published under the subscription model but it is now published under an Open Access license.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was funded by NHS England.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The review was restricted to evidence available in the public domain. Formal ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The review reported in this manuscript was funded by NHS England. The views expressed are those of the authors and not necessarily those of NHS England. The funder had no role in the decision to publish the findings.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements and Declarations"}},{"value":"Edward Wilson is an editorial board member of Applied Health Economics and Health Policy but was not involved in the selection of peer reviewers for the manuscript nor any subsequent decisions. The remaining authors have no relevant financial or non-financial interests to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The authors confirm that all data generated or analysed during this study are based on published studies.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication (from Patients\/Participants)"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Concept and design: Farmer, Wilson, Lee. Acquisition of data: Trigg, Farmer, Muthukumar, Wilson, Lovell, Lee. Analysis and interpretation of the data: Trigg, Farmer, Muthukumar, Wilson, Lee. Drafting of the manuscript: Trigg, Farmer, Muthukumar, Wilson, Lovell, Lee. Critical revision of paper: Farmer, Wilson, Lee. Statistical analysis: Trigg, Farmer, Muthukumar, Wilson, Lovell, Lee. Obtaining funding: Farmer, Wilson, Lee.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}